助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   早期肾癌 的翻译结果: 查询用时:0.3秒
图标索引 在分类学科中查询
所有学科
更多类别查询

图标索引 历史查询
 

早期肾癌
相关语句
  early stage rcc
     While MVD has no value in prognostic evaluation for early stage RCC.
     MVD对早期肾癌预后的判断价值不大。
短句来源
  “早期肾癌”译为未确定词的双语例句
     Furthermore, the positive expression of P selectin was higher in patients with advanced renal cell carcinoma (stage Ⅲ and Ⅳ)than early stages (stage Ⅰ and Ⅱ) (87.5% vs 33.3%, P <0.05).
     晚期肾癌(Ⅲ、Ⅳ期)阳性表达率为875%(7/8),明显高于早期肾癌(Ⅰ、Ⅱ期)的333%(4/12),P<005。
短句来源
     3、MVD parameter was 101.24±42.82 in RCC and 74.03±36.06 in control group, Statistic significance existed between the two groups(p<0.05).
     3、肿瘤组MVD计数为101.24±42.82,晚期肾癌组为115.49±41.28,早期肾癌组为92.33±41.74,对照组为 74.03±36.06。 肿瘤组和对照组间差异具有显著性(P<0.05),晚期肾癌组和早期肾癌组间差异有显著性(P<0.05)。
短句来源
     ②The detection and characterization as well as accuracy of staging in 20 early RCC on MSCT were 100%, 95%, and 95%, respectively.
     ②本组早期肾癌检出率100%,定性诊断率95%,分期准确度为95%。
短句来源
     The positive expression of MRP was higher in patients with advanced renal cell carcinoma of stage Ⅲ and stage Ⅳ than stage Ⅰ and Ⅱ (89% vs 36%, P <0.05).
     晚期肾癌(Ⅲ、Ⅳ期)阳性表达率为89%,明显高于早期肾癌(Ⅰ、Ⅱ期)的36%,P<005。
短句来源
     Value of MSCT in the diagnosis of early renal cell carcinoma
     MSCT多期扫描在早期肾癌诊断中的应用价值
短句来源
更多       
  相似匹配句对
     Objective To investigate a biomarker pattern for the early diagnosis of renal cell carcinoma (RCC).
     目的探讨早期诊断的新方法。
短句来源
     Optimal margin in nephron-sparing surgery for renal cell carcinoma 4 cm or less in diameter
     早期手术切除范围的探讨
短句来源
     Results In renal cell carcinoma.
     结果 在中.
短句来源
     Explotation of safety margin in nephron-sparing surgery in the patients with early renal cell carcinoma
     早期手术安全范围的研究
短句来源
     The progress of the immune therapy of renal cell carcinoma
     免疫治疗进展
短句来源
查询“早期肾癌”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  early stage rcc
Adrenal involvement is not likely in patients with localized early stage RCC, and adrenalectomy is unnecessary in such cases, particularly when the CT is negative.
      
Therefore, the 5?cm cutoff seems to best determine the clinical prognosis of patients undergoing tumor nephrectomy for early stage RCC.
      
Preoperative and annual postoperative ultrasonography may be useful in identifying early stage RCC.
      


The gray scale ultrasonic (BUS) features of 82 cases of renal tumors confirmed histologically were analyzed. There were 72 malignant and 10 benign tumors. The aiagnostic accuracy rate of BUS was 89%, with 9 (11%) misdiagnosed. On sonography, benign tumor usually showed smooth and clear-cut contour, regular shape, uniform echo, and increased echo from the posterior wall of the tumor. The malignant one, however, usually manifested as an irregular mass with blurred margin and uniform echo, and the echo on its posterior...

The gray scale ultrasonic (BUS) features of 82 cases of renal tumors confirmed histologically were analyzed. There were 72 malignant and 10 benign tumors. The aiagnostic accuracy rate of BUS was 89%, with 9 (11%) misdiagnosed. On sonography, benign tumor usually showed smooth and clear-cut contour, regular shape, uniform echo, and increased echo from the posterior wall of the tumor. The malignant one, however, usually manifested as an irregular mass with blurred margin and uniform echo, and the echo on its posterior wall was decreased. In 8 "early" renal cancers (tumor size less than 5cm in diameter) in this series, 6 were asymptomatic, IVP was positive in 3 of 6, and CT was positive in A of 5. But all these cases were diagnosed correctly by BUS. It is evident that BUS is a safe and reliable method in the diagnosis of renal tumor, and can be considered as a first choice.

本文报告灰阶超声诊断肾肿瘤82例,均经手术和病理证实。其中良性10例,恶性72例,诊断符合率为89%,误诊9例占11%。本文根据肾肿瘤的不同声像图特点来鉴别良、恶性肿瘤,并分别对肾癌、肾盂癌、肾内瘤的声像图表现加以重点描述。认为良性肿瘤的声像图边缘清楚、规则、内部回声均匀,后壁回声增强。恶性肿瘤则多数边缘模糊,不规则,内部回声不均匀,后壁回声衰减。 8例小于5cm的早期肾癌,6例无临床症状;6例经IVP检查,阳性仅3例;CT检查5例,阳性4例;而超声诊断均与手术病理完全符合。证明灰阶超声检查方法完全、方便,对诊断肾肿瘤列为首选手段优于其它检查方法,具有独到之处。

eripheral blood T lymphocyte subsets and mIL- 2R in 20 patients with reaal carcinoma and 40 normal controls were detected quantitatively with FCM. The results show tat the renal carcinoma patients’cell immunity including T-cell subsets and mIL-2R expression weredepressed, and the changes of T- cell subsets the ratio of CD4/CD8 and mIL-2R were related to the tumor stages and prognosis,but not to the histological type,and patients’ cell immu-nity may be improved by removing the tumor.

用流式细胞计对20例肾癌患者及40例正常对照者外周血T淋巴细胞亚型、NK细胞及mIL-2R进行了定量检测,并将患者细胞免疫功能变化与肾癌临床分期、病理类型及手术前后比较。结果:(1)肾癌组除CD8增高外各项免疫指标均明显低于正常对照组;(2)晚期肾癌各项免疫指标与正常对照均有显著差别,除CD3,NK无明显变化外,其他各项免疫指标均与早期肾癌组有显著差别;(3)肾癌各分型之间细胞免疫功能无明显差别;(4)与术前相比,术后患者外周血CD3、CD4、NK细胞和mIL-2R均明显升高,CD8则明显降低。结果提示:(1)肾癌患者的细胞免疫力功能受到抑制。并随病情的进展、肿瘤的转移而进一步加剧;(2)外周血CD4/CD8比值、mIL-2R等可评估肾癌患者的病情程度和预后;(3)手术切除原发灶可部分恢复肾癌患者的细胞免疫功能。

Expression of P selectin was detected by LSAB immunohistochemistry in renal tissue of 20 patients with renal cell carcinoma. The result revealed that P selectin was positively expressed in 11(55.5%), being not only on the endothelium of intratumoral vessels but also on the membrane of carcinonma cells. Furthermore, the positive expression of P selectin was higher in patients with advanced renal cell carcinoma (stage Ⅲ and Ⅳ)than early stages (stage Ⅰ and Ⅱ) (87.5% vs 33.3%, P <0.05). These suggested that...

Expression of P selectin was detected by LSAB immunohistochemistry in renal tissue of 20 patients with renal cell carcinoma. The result revealed that P selectin was positively expressed in 11(55.5%), being not only on the endothelium of intratumoral vessels but also on the membrane of carcinonma cells. Furthermore, the positive expression of P selectin was higher in patients with advanced renal cell carcinoma (stage Ⅲ and Ⅳ)than early stages (stage Ⅰ and Ⅱ) (87.5% vs 33.3%, P <0.05). These suggested that P selectin might play an important role in the tumor metastasis and in the prognosis of renal cell carcinoma.

为探讨P选择素在肾癌中的表达意义,应用免疫组化链菌素抗生物素蛋白生物素酶标法(LSAB)法检测20例肾癌患者肾组织中P选择素表达。结果发现,P选择素阳性表达率为555%(11/20),不仅在肿瘤血管内皮上表达,也在肿瘤细胞膜上表达。晚期肾癌(Ⅲ、Ⅳ期)阳性表达率为875%(7/8),明显高于早期肾癌(Ⅰ、Ⅱ期)的333%(4/12),P<005。提示P选择素与肾癌浸润转移有关,并可能是一种新的肾癌转移及预后指标。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关早期肾癌的内容
在知识搜索中查有关早期肾癌的内容
在数字搜索中查有关早期肾癌的内容
在概念知识元中查有关早期肾癌的内容
在学术趋势中查有关早期肾癌的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社